JP2014514361A5 - - Google Patents

Download PDF

Info

Publication number
JP2014514361A5
JP2014514361A5 JP2014510467A JP2014510467A JP2014514361A5 JP 2014514361 A5 JP2014514361 A5 JP 2014514361A5 JP 2014510467 A JP2014510467 A JP 2014510467A JP 2014510467 A JP2014510467 A JP 2014510467A JP 2014514361 A5 JP2014514361 A5 JP 2014514361A5
Authority
JP
Japan
Prior art keywords
functional food
food composition
composition
composition according
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014510467A
Other languages
English (en)
Japanese (ja)
Other versions
JP6027607B2 (ja
JP2014514361A (ja
Filing date
Publication date
Priority claimed from US13/105,470 external-priority patent/US9439875B2/en
Application filed filed Critical
Publication of JP2014514361A publication Critical patent/JP2014514361A/ja
Publication of JP2014514361A5 publication Critical patent/JP2014514361A5/ja
Application granted granted Critical
Publication of JP6027607B2 publication Critical patent/JP6027607B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014510467A 2011-05-11 2012-05-10 プテロスチルベンの抗不安効果 Expired - Fee Related JP6027607B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/105,470 2011-05-11
US13/105,470 US9439875B2 (en) 2011-05-11 2011-05-11 Anxiolytic effect of pterostilbene
PCT/US2012/037325 WO2012154956A2 (en) 2011-05-11 2012-05-10 Anxiolytic effect of pterostilbene

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016202351A Division JP2017014284A (ja) 2011-05-11 2016-10-14 プテロスチルベンの抗不安効果

Publications (3)

Publication Number Publication Date
JP2014514361A JP2014514361A (ja) 2014-06-19
JP2014514361A5 true JP2014514361A5 (cg-RX-API-DMAC10.html) 2015-05-28
JP6027607B2 JP6027607B2 (ja) 2016-11-16

Family

ID=47140003

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014510467A Expired - Fee Related JP6027607B2 (ja) 2011-05-11 2012-05-10 プテロスチルベンの抗不安効果
JP2016202351A Withdrawn JP2017014284A (ja) 2011-05-11 2016-10-14 プテロスチルベンの抗不安効果

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016202351A Withdrawn JP2017014284A (ja) 2011-05-11 2016-10-14 プテロスチルベンの抗不安効果

Country Status (9)

Country Link
US (1) US9439875B2 (cg-RX-API-DMAC10.html)
EP (1) EP2706992B1 (cg-RX-API-DMAC10.html)
JP (2) JP6027607B2 (cg-RX-API-DMAC10.html)
KR (1) KR101929074B1 (cg-RX-API-DMAC10.html)
CN (1) CN103561729B (cg-RX-API-DMAC10.html)
AU (1) AU2012253479B2 (cg-RX-API-DMAC10.html)
BR (1) BR112013028776B1 (cg-RX-API-DMAC10.html)
CA (1) CA2839309C (cg-RX-API-DMAC10.html)
WO (1) WO2012154956A2 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9439875B2 (en) * 2011-05-11 2016-09-13 The United States Of America, As Represented By The Secretary Of Agriculture Anxiolytic effect of pterostilbene
EP2968368B1 (en) 2013-03-15 2017-08-09 Glia LLC Cranial delivery of pharmaceuticals
CN103333141B (zh) * 2013-06-05 2015-04-29 宁波大学 一种白藜芦醇低聚茋类化合物及其制备方法和应用
JP6406865B2 (ja) * 2014-04-25 2018-10-17 森永製菓株式会社 濃度測定方法
JP6463956B2 (ja) * 2014-11-28 2019-02-06 キユーピー株式会社 乳化組成物及びその製造方法
CN104706627A (zh) * 2015-03-12 2015-06-17 厦门大学 一种治疗缺血性脑中风的药物
US20190076376A1 (en) 2015-07-10 2019-03-14 University Of Miami Methods for treating mucopolysaccharidosis
JP7132907B2 (ja) 2016-08-22 2022-09-07 エリジウム・ヘルス・インコーポレイテッド ニコチンアミドリボシド及びプテロスチルベン組成物及び神経変性障害の治療方法
EP3624808A4 (en) * 2017-05-18 2021-03-03 Elysium Health, Inc. PROCEDURES AND COMPOSITIONS FOR IMPROVED SLEEP
JP6619108B2 (ja) * 2019-01-07 2019-12-11 キユーピー株式会社 乳化組成物及びその製造方法
CN111569084B (zh) * 2019-02-19 2021-07-13 中国科学院上海药物研究所 基于柳胺酚和紫檀芪的成环偶联分子dcz0801类化合物、其制备方法及用途
CN110075094A (zh) * 2019-02-27 2019-08-02 延边大学 紫檀芪在制备药物或保健品中的应用
CN112618520A (zh) * 2021-01-14 2021-04-09 姚大纯 紫檀芪或白藜芦醇在制备用于治疗或改善孤独症谱系障碍的药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006020999A2 (en) * 2004-08-19 2006-02-23 The United States Of America, As Represented By The Secretary Of Agriculture Pterostilbene as a new agonist for the peroxisome proliferator-activated receptor alpha isoform
TW200640529A (en) * 2005-02-28 2006-12-01 Thomas Christian Lines Composition for treating mental health disorders
WO2008039863A2 (en) * 2006-09-27 2008-04-03 Braincells, Inc. Composition comprising a melanocortin receptor (mcr) modulating agent alone or in combination with a second neurogenic agent for treating nervous system disorders
US20090069444A1 (en) * 2007-09-07 2009-03-12 The United States Of America, As Represented By Th E Secretary Of Agriculture Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration
US20090163580A1 (en) * 2007-12-24 2009-06-25 Natrol, Inc. Anti-aging composition containing resveratrol and method of administration
JP5526762B2 (ja) * 2009-02-17 2014-06-18 Jnc株式会社 誘電率異方性が負の液晶性化合物、これを用いた液晶組成物および液晶表示素子
WO2010095926A1 (en) * 2009-02-20 2010-08-26 N.V. Nutricia Use of reveratrol for preserving cognitive functioning
EP2445488B1 (en) * 2009-06-22 2020-03-18 Indus Biotech Private Limited Process for obtaining purified pterostilbene and methods of use thereof
EP2322159A1 (en) * 2009-10-30 2011-05-18 Green Molecular, S.L. Use of pterostilbene (pter) as medicament for prevention and/or treatment of skin diseases, damages or injures or as cosmetic
US9439875B2 (en) * 2011-05-11 2016-09-13 The United States Of America, As Represented By The Secretary Of Agriculture Anxiolytic effect of pterostilbene

Similar Documents

Publication Publication Date Title
BR112015014800A2 (pt) derivados da exendina-4 funcionalizada
ECSP13012379A (es) Pirimidinas y triazinas condensadas y su uso
JP2012144538A5 (cg-RX-API-DMAC10.html)
JP2012529334A5 (cg-RX-API-DMAC10.html)
WO2012054526A3 (en) Chemosensory receptor ligand-based therapies
ES2445846R1 (es) Una composición de combinación farmacéutica y su uso para preparar un medicamento destinado al tatamiento de la diabetes de tipo l y los trastornos metabólicos
JP2012136529A5 (cg-RX-API-DMAC10.html)
WO2012054527A3 (en) Chemosensory receptor ligand-based therapies
WO2012054528A3 (en) Chemosensory receptor ligand-based therapies
JP2014500291A5 (cg-RX-API-DMAC10.html)
WO2012054530A3 (en) Chemosensory receptor ligand-based therapies
HU0700024D0 (en) Use of enhancers in biglycan activuty in the preparation of pharmaceutical compositions having utility in cardiac diseases
CA2834182C (en) Honey composition with l-alanyl-l-glutamine
GB201220630D0 (en) Kissorphin peptides for use in the treatment of alzheimer's disease, creutzfeldtjakob disease or diabetes mellitus
Bryant Poetry: Grief and Hope
CN302053750S (zh) 汽车扰流板(w)
Woods Sleep disturbances (ages 0-12)
Cortes et al. Rubella in pregnancy
CN302053756S (zh) 汽车控制面板(w)
TH121370S (th) ผ้าเบรคสำหรับรถยนต์
TH47881S1 (th) ผ้าเบรคสำหรับรถยนต์
CN302291275S (zh) 马桶
TH47568S1 (th) ตัวถังรถยนต์
TH120577S (th) ตัวถังรถยนต์
TH121907S (th) ชิ้นส่วนอุปกรณ์ล็อคเกียร์สำหรับรถยนต์